Skip to content

Mandibular Overdentures vs All-on-4 With PEEK

Long-Term Peri-Implant Outcomes of Mandibular Overdentures and All-on-4 Prostheses With PEEK Frameworks

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07137533
Enrollment
40
Registered
2025-08-22
Start date
2025-08-01
Completion date
2025-10-25
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Loss in Jaw

Brief summary

This study compares long-term peri-implant outcomes between two mandibular full-arch rehabilitation approaches-four-implant-retained overdentures and All-on-4 fixed prostheses-when both are fabricated with polyetheretherketone (PEEK) frameworks. While overdentures and All-on-4 prostheses are widely used, evidence on the clinical performance of PEEK frameworks in these modalities is scarce. By evaluating marginal bone loss and other peri-implant parameters, the research aims to clarify whether prosthetic design influences biological outcomes when using this high-performance polymer.

Detailed description

Mandibular edentulism significantly compromises mastication, speech, and psychosocial well-being. Implant-supported prostheses-particularly four-implant-retained overdentures and the All-on-4 full-arch fixed prosthesis-are well-established solutions for restoring function and quality of life. The overdenture approach provides a removable, cost-effective option with enhanced retention and stability, while the All-on-4 concept offers a fixed, immediately functional solution by placing two anterior straight implants and two posterior tilted implants within the interforaminal region. Long-term success of both treatment modalities is influenced by peri-implant outcomes, especially marginal bone loss (MBL), which reflects the biological stability of the implant-bone interface. MBL can be affected by multiple factors, including loading protocols, implant angulation, prosthetic design, and material properties of the prosthetic framework. Recent advances in materials science have introduced polyetheretherketone (PEEK), a high-performance polymer, as a promising alternative to traditional metallic frameworks such as titanium or cobalt-chromium. PEEK offers mechanical properties that closely mimic bone, excellent biocompatibility, chemical stability, and a lower elastic modulus that may provide beneficial shock absorption, potentially reducing stress on implants and peri-implant bone. When fabricated via CAD/CAM technology, PEEK frameworks achieve high marginal accuracy and favorable fracture resistance, while also being lightweight and comfortable for patients. Despite growing interest in PEEK for dental applications, most clinical research has focused on its use in removable partial dentures or single crowns. Data on its performance in full-arch implant prostheses-whether overdentures or All-on-4 fixed restorations-are scarce. Moreover, few studies have directly compared the peri-implant outcomes of these two rehabilitation strategies when using the same framework material.

Interventions

OTHERMandibular Four-Implant-Retained Overdenture (PEEK Framework); Mandibular All-on-4 Fixed Prosthesis (PEEK Framework)

Group I: Four-implant-retained mandibular overdenture with a CAD/CAM-milled PEEK framework and acrylic denture teeth, retained via attachment mechanisms; implants placed in lateral incisor and first premolar sites; delayed loading protocol. Group II: Mandibular All-on-4 fixed prosthesis with a CAD/CAM-milled PEEK framework and acrylic denture teeth; two anterior straight and two posterior tilted implants placed in lateral incisor and first premolar sites; delayed loading protocol.

Sponsors

Mansoura University
CollaboratorOTHER
Menoufia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years

Inclusion criteria

Adults aged ≥40 years. Completely edentulous mandible for at least 6 months prior to implant placement. Treated with either: Four-implant-retained mandibular overdenture with a PEEK framework, or Mandibular All-on-4 fixed prosthesis with a PEEK framework. All implants placed in the lateral incisor and first premolar regions (per respective protocol). Restorations fabricated via CAD/CAM-milled PEEK framework with acrylic denture teeth. Prosthesis delivered with a delayed loading protocol. Minimum clinical and radiographic follow-up of 4 years. Availability of standardized baseline and follow-up periapical radiographs for marginal bone level assessment. Treated by the same surgical and prosthodontic team.

Exclusion criteria

History of uncontrolled systemic diseases that could affect bone healing (e.g., uncontrolled diabetes, osteoporosis under bisphosphonate therapy). History of head and neck radiotherapy. Active periodontal or peri-implant infection at the time of implant placement. Insufficient bone volume in the interforaminal region requiring grafting beyond minor augmentation. Heavy smoking habit (\>10 cigarettes/day) at the time of treatment. Parafunctional habits (e.g., severe bruxism or clenching) documented in patient records. Use of medications known to affect bone metabolism (e.g., high-dose corticosteroids, antiresorptive drugs). Pregnancy at the time of implant placement. Incomplete clinical or radiographic records. Follow-up period of less than 4 years.

Design outcomes

Primary

MeasureTime frameDescription
Marginal Bone Loss (MBL) per implant (mm)5 yearsDefinition: Change in crestal bone level on the mesial and distal aspects of each implant from baseline to last follow-up. Baseline: Prosthesis delivery (insertion) radiograph. Follow-up window: Minimum 48 months post-insertion (target range ≈ 4-9 years, depending on patient record length). Measurement method: Standardized periapical radiographs using a paralleling technique

Countries

Egypt

Contacts

Primary ContactMohammed A. El-Sawy, PhD
Dr_sawy@windowslive.com00201061314522
Backup ContactMohammed T. Khater, PhD
MohamedKhaterdentalsmile1234@gmail.com00201003854552

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026